For example, EZH2 methyltransferase activity in hepatocellular carcinoma cells caused H3K27me3 histone modification near IRF1 and CD274 promoter regions, which suppressed their expression without affecting the IFNγ/STAT1 signaling pathway [70]. The gene discussed is CD274; the disease is hepatocellular carcinoma.